Table 1.
Demographic, behavioral, and clinical characteristics among Women’s Interagency HIV Study participants. (n=1583)
| Variables | Overall |
|---|---|
| n (%) | |
| HIV serostatus | |
| HIV seropositive | 1123 (70.9) |
| HIV seronegative | 460 (29.1) |
| Age at visit, mean (SD) | 50.8 (9.3) |
| Race/ethnicity | |
| Non-Hispanic Black | 985 (62.2) |
| Hispanic | 207 (13.1) |
| Non-Hispanic other | 249 (15.7) |
| Non-Hispanic White | 142 (9.0) |
| Education | |
| <High school | 487 (30.8) |
| High school | 516 (32.6) |
| >High school | 579 (36.6) |
| Income, ≤$18,000/year | 958 (61.5) |
| Unemployed | 949 (60.0) |
| Unstable housing | 264 (16.7) |
| Partner status, no partner | 1128 (72.0) |
| Cigarette smoker, current | 596 (37.7) |
| Hazardous alcohol, >7 drink/wk | 131 (8.3) |
| Non-injection druga, current | 418 (26.4) |
| Injection drugb, ever | 251 (15.9) |
| Menopausal status | |
| Menopausal | 679 (42.9) |
| Not menopausal | 651 (41.1) |
| N/A due to hysterectomy | 253 (16.0) |
| Body mass index (BMI), mean (SD) | 32.7 (9.1) |
| Underweight | 26 (1.6) |
| Normal | 263 (16.8) |
| Overweight | 400 (25.5) |
| Obese | 880 (56.1) |
| Depressive symptoms (CES-D), median (IQR) | 8 (3-18) |
| Anxiety symptoms (GAD-7), median (IQR) | 2 (0-7) |
| HIV positive participants (n=1123) | |
| CD4 count (cells/mm3), median (IQR) | 680 (473 – 918) |
| CD4 count below 350 | 157 (14.0) |
| Detected viral load | 400 (35.7) |
| Viral load (copies/mL), median (IQR) | 98 (36 – 1115) |
| cART adherence, ≥95% | 902 (85.4) |
Due to missing data, counts may not add up to total n=1583. Data presented as counts (frequency), unless otherwise noted.
a
Non-injected recreational drugs use since last visit. Includes crack, cocaine, and/or heroin use, any marijuana use, hallucinogens, club drugs and methamphetamines.
b
Ever reported use